Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03298958
Title Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications

urinary bladder cancer

Therapies

Sirolimus

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.